Analyst Ratings for Palvella Therapeutics (PVLA)
PVLA Rating Summary
PVLA Price Target Summary
- Highest: $270.00 (H.C. Wainwright)
- Lowest: $90.00 (LifeSci Capital)
- Average: $215.94
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$215.94 (+90.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/12/2026 | Stephens | Sudan Loganathan | New Coverage | Overweight (N/A) |
220.00 (N/A) |
121.29 (113.10) |
-6.75% | Details |
| 5/4/2026 | Oppenheimer | Leland Gershell | New Coverage | Outperform (N/A) |
210.00 (N/A) |
126.84 (113.10) |
-10.83% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
